Bernstein’s $500 Target Says UnitedHealth’s Selloff Went Too Far

David Hanson • 4 minute read
Reviewed by: David Hanson
Last updated Nov 19, 2026

@photobyphotoboy via Canva, @NATEE MEEPIAN from Natee Meepian's Images via Canva

Key Takeaways

  • UnitedHealth Group is 28% below its 52-week high after a federal plan to widen Medicare Advantage audits, and Bernstein reiterated its $500 price target on Nov. 19, 51% above the price.
  • The same audit plan hit Humana, and Sen. Elizabeth Warren’s call to break up integrated health giants named CVS Health along with UnitedHealth.
  • On analysts’ 2028 earnings estimates, $500 is 18x, just under the stock’s five-year average forward P/E of 19x.
  • Bernstein’s call looks right, though the audit rule threatens the 2028 earnings the target rests on, and the rule won’t be settled before comments close Jan. 19, 2027.

UnitedHealth Group (UNH) is 28% below its 52-week high after a rough stretch in Washington. On Nov. 19, Bernstein reiterated its Outperform rating and $500 price target, 51% above the price.

Washington piles on

On Nov. 16, the Centers for Medicare & Medicaid Services proposed extrapolating Medicare Advantage audit findings to whole contracts and clawing back overpayments as far back as 2018. CMS puts the take at about $9 billion per payment year industry-wide, and UnitedHealth hasn’t sized its share.

UnitedHealth fell 10% on Nov. 18 after an update from CMS on the proposal, and Humana (HUM) lost 13%. The same day, Sen. Elizabeth Warren called for breaking up UnitedHealth, CVS Health (CVS) and Cigna, writing on X that the three “take a cut at every step.”

Bernstein already trimmed for politics

Bernstein cut its target to $500 from $512 in mid-October. It said multiple expansion faced headwinds because investors were turning to 2028 Medicare rates and the 2028 presidential primaries. So Bernstein expected Washington to cap the multiple, and it stood by $500 anyway.

UnitedHealth earned $4.69 of adjusted EPS in the third quarter, up from $2.92 a year earlier. CFO Wayne DeVeydt said on the call that “current analyst consensus for 2027 may understate the opportunity ahead.”

TIKR tracks 26 analysts on UnitedHealth. How many say “Buy”?

See the full breakdown of Buy, Hold, and Sell ratings on UnitedHealth, along with Wall Street’s revenue and earnings estimates, all in one place. More than 500,000 investors use TIKR to research stocks like this one. See UnitedHealth’s Analyst Ratings

Does $500 add up?

Wall Street’s consensus target has climbed to $476 from $387 a year ago:

Line chart from TIKR of UnitedHealth Group's analysts' consensus (mean) price target, $ per share, last year.
UnitedHealth Group (UNH): analysts’ consensus (mean) price target, $ per share, last year (TIKR)

Bernstein’s $500 is 5% above it. Analysts expect normalized EPS to climb from $20.52 this year to $27.09 in 2028, close to the $27.66 UnitedHealth earned in 2024:

Bar chart from TIKR of UnitedHealth Group's normalized EPS, actual and consensus estimates, $ per share, fiscal 2024-2028.
UnitedHealth Group (UNH): normalized EPS, actual and consensus estimates, $ per share, fiscal 2024-2028 (TIKR)

The audit rule could pull that 2028 figure down. Oppenheimer expects most recoveries to land in 2028-2030, which puts 2028 earnings most at risk.

The stock trades at 15x forward earnings, well under its five-year average of 19x, and today’s price takes it lower still:

Line chart from TIKR of UnitedHealth Group's forward (NTM) P/E, last 5 years.
UnitedHealth Group (UNH): forward (NTM) P/E, last 5 years (TIKR)

By my math, $500 is 18x analysts’ 2028 estimate, a touch under that average. To get there, earnings have to rise about a fifth above the next twelve months’ estimate, and the multiple has to climb back to 18x from 15x.

I’m with Bernstein

The audit rule is a genuine risk, but I think Bernstein has this one right. Its target asks for less than UnitedHealth’s usual multiple, and analysts have raised their 2027 estimates to $23.34 from $22.44 over the past three months.

The next test is management’s 2027 outlook, due before year-end. A guide at or above $23.34 would back the CFO. Comments on CMS’s rule close Jan. 19, 2027.

So what is UnitedHealth stock actually worth?

TIKR lets you forecast the future price of any stock in less than a minute. Just enter a few assumptions into TIKR’s valuation model and see what UnitedHealth could be worth. Start from Wall Street consensus estimates, or adjust the inputs to reflect your own view of the business. It’s free to use.

Value UnitedHealth for free

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required